Clinical Outcomes and Prognostic Factors Associated With Acanthamoeba Keratitis : Cornea

Secondary Logo

Journal Logo

Clinical Science

Clinical Outcomes and Prognostic Factors Associated With Acanthamoeba Keratitis

Chew, Hall F MD, FRCS(C); Yildiz, Elvin H MD; Hammersmith, Kristin M MD; Eagle, Ralph C Jr MD; Rapuano, Christopher J MD; Laibson, Peter R MD; Ayres, Brandon D MD; Jin, Ya-Ping MD, PhD; Cohen, Elisabeth J MD

Author Information
Cornea 30(4):p 435-441, April 2011. | DOI: 10.1097/ICO.0b013e3181ec905f

Abstract

Purpose: 

To describe the clinical characteristics, time of presentation, risk factors, treatment, outcomes, and prognostic factors on a recent series of Acanthamoeba keratitis (AK) treated at our institution.

Methods: 

Retrospective case series of 59 patients diagnosed with AK from January 1, 2004 to December 31, 2008. Of these 59 patients, 51 had complete follow-up data and were analyzed using univariate and multivariate logistic regression analyses performed with “failure” defined as requiring a penetrating keratoplasty (PKP) and/or having (1) best-corrected visual acuity (BCVA) <20/100 or (2) BCVA <20/25 at the last follow-up. A single multivariate model incorporating age, sex, steroid use before diagnosis, time to diagnosis, initial visual acuity (VA), stromal involvement, and diagnostic method was performed.

Results: 

Symptom onset was greatest in the summer and lowest in the winter. With failure defined as requiring PKP and/or final BCVA <20/100, univariate analysis suggests that age >50 years, female sex, initial VA <20/50, stromal involvement, and patients with a confirmed tissue diagnosis had a significant risk for failure; however, none of these variables were significant using multivariate analysis. Univariate analysis, with failure defined as requiring PKP and/or final BCVA <20/25, showed stromal involvement and initial VA <20/50 were significant for failure-only initial VA <20/50 was significant using multivariate analysis.

Conclusions: 

Symptom onset for AK is greatest in the summer. Patients with confirmed tissue diagnosis and female patients may have a higher risk for failure, but a larger prospective population-based study is required to confirm this. Failure is likely associated with patients who present with stromal involvement and patients presenting with an initial BCVA worse than 20/50.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid